Skip to main content
. 2013 Jan 7;4(1):4. doi: 10.1186/scrt152

Figure 2.

Figure 2

Myostatin genetic inactivation does not block the multipotent nonmyogenic differentiation capacity of MDSCs. Representative pictures of proliferating MDSCs treated for 2 weeks in differentiation media and subjected to immunocytochemistry for NF-70 (A) and ASMA (B) to detect marker expression of neural cells and myofibroblasts (200×). MDSC, muscle-derived stem cell; WT, wild type (muscle-derived stem cells); KO, myostatin knockout (muscle-derived stem cells); ASMA, α-smooth muscle actin.